| | FREE WEBINAR: Decoding the Vaginal Microbiome Don't miss the chance to hear Priyanka Jain, CEO & Co-Founder at Evvy discuss their mission to close the gender health gap by leveraging overlooked biomarkers and using metagenomic sequencing to better understand the vaginal microbiome. Register Now! |
|---|
Ex-Takeda leader to provide steady hand as Tessa's CEO after C-suite churn 2 biotechs swoop into monkeypox scene with new R&D licensing pact The top 10 global R&D institutes of 2021 After FDA rejection, Gilead's long-acting HIV med Sunlenca snags first global nod Insulet's Omnipod 5 insulin pump scores FDA nod for toddlers with Type 1 diabetes Eisai inaugurates new US HQ as closely watched FDA Alzheimer's decision draws near Biden admin releases final surprise billing rule that updates dispute resolution process after legal setbacks Pharma ad spending up just 1% this year as the slow move away from TV into digital continues Employer health costs set to rise 6.5% in 2023: Aon Featured Story | By Gabrielle Masson Former Takeda exec Thomas Willemsen will be taking the reins as Tessa Therapeutic’s new president and CEO as the CAR-T biotech gears up in anticipation of several clinical milestones. read more |
| |
|---|
|
Top Stories By Gabrielle Masson Lytic Solutions has circled in on NightHawk Biosciences’ monkeypox vaccine science, penning a licensing deal with the ultimate goal of developing a vaccine that will address a potential monkeypox pandemic. read more By Max Bayer Advances in the biomedical industry are often a function of quality research produced at academic research institutions around the world. This year's list of top R&D outposts had a number of changes, namely the addition of more Chinese institutions. read more By Angus Liu Nearly six months after an FDA rejection, Gilead Sciences’ next-generation, long-acting HIV med lenacapavir has picked up its global-first approval in Europe. But the company still needs to find the first-in-class drug a proper combination partner after a high-profile Merck setback. read more By Andrea Park Just a few weeks into the full-scale rollout of its Omnipod 5 insulin pump, Insulet has gotten the green light to expand the device’s reach even further. read more By Angus Liu Eisai officially launched its new U.S. headquarters just as the Japanese pharma looks to expand its commercial presence with an Aduhelm follow-up in Alzheimer’s disease by “building trust with the public.” read more By Heather Landi The Biden administration released Friday a final rule that updates the arbitration process providers and insurers can use to settle out-of-network billing disputes after the federal government suffered several legal setbacks to the No Surprises Act. read more By Ben Adams The pharma industry spent just 1% more on all product ads for the first half of this year compared to the same period in 2021, while prescription drug ad spending actually fell. read more By Paige Minemyer This is more than double the 3% increase that employers saw in 2022 but far below the current inflation index, according to Aon. read more Resources Sponsored by: Ferma.AI, a Product of ZoomRx Improve your congress competitive intelligence and cut down costs by 50% Sponsored by: Catalent Learn more about how the transition from early to late phase of a small molecule program plays a pivotal role in a program’s ultimate success. Sponsored by: Bio-Techne Advanced research requires advanced tools. Our next-generation ELISA takes a fraction of the time to run eight analytes simultaneously while saving your sample volume. Simply load, scan, and insert your cartridge and come back to fully analyzed results in 75 minutes. Rethink your ELISA, with Ella. Sponsored by: Thermo Fisher Scientific Set a solid foundation for successful scale-up of buffer preparation. The total immersion, transformative training will take place at the Harvard Club in Boston. VIRTUAL in real time is also available. Contingencies for COVID19 will apply. Register NOW for a large early bird discount www.drugstomarket.com/drugbootcamp. Sponsored by: Triangle Insights Group, LLC The TrialCard/Triangle Insights Group platform is uniquely positioned to support you as your asset progresses through the value chain, by integrating strategic commercialization and market access insights with comprehensive patient and provider support services. Sponsored by: Thermo Fisher Scientific See how integration of innovative genetic analysis techniques into drug development is driving biopharma & biotech companies ahead. Sponsored by: Catalent What is the most suitable dosage form technology for the Oral Delivery of Lipid-Based Formulations? Sponsored by: Catalent Learn how formulation development for a PFS affects manufacturing to drive the industry toward optimizing delivery of injectable products and, ultimately, improving patient care. Sponsored by: Catalent Did you know Catalent has newly expanded in-house capabilities spanning clinical and commercial scale manufacturing for DPIs, unit-dose, bi-dose and preserved multi-dose nasal sprays? Sponsored by: Catalent What are key considerations for intranasal delivery in the treatment of acute and chronic conditions? Sponsored by: Catalent Learn more about how the versatility of Softgel Technology helped a customer with a volatile compound. Sponsored by: Catalent How can Lipid-Based Drug Delivery System help bring poorly soluble drugs to market? Sponsored by: Catalent Carla Vozone discusses the significant trends in the OINDP segment including large molecules and novel indications, changes within CDMOs and various challenges facing the industry. Sponsored by: Catalent Ypsomed and Catalent Biologics experts discuss strategies for integrated PFS manufacturing and auto-injector assembly to accelerate timelines and more in this webinar. | 